KELOWNA, BRITISH COLUMBIA--(Marketwire - March 25, 2008) - Sernova Corp. ("Sernova") (TSX VENTURE: SVA) is pleased to announce that world class, pancreatic islet transplant expert, Dr. Shinichi Matsumoto, Director of the Baylor All Saints Islet Cell Laboratory at the Baylor Research Institute in Fort Worth Texas, has accepted an appointment to Sernova's Scientific Advisory Board (SAB). Dr. Matsumoto is a pioneer in human islet transplantation to treat diabetics. He has many notable accomplishments in the field of islet transplantation, which will assist Sernova in pursuing its clinical regulatory path going forward. His research has resulted in numerous scientific publications on islet isolation, preparation and transplantation.
